Implementing community pharmacy-based influenza point-of-care test-and-treat under collaborative practice agreement

BACKGROUND: Early and accessible testing for influenza with point-of-care testing (POCT) can be a critical factor for deciding to begin antiviral treatment. More than 10,000 pharmacies across the USA offer Clinical Laboratory Improvement Amendments-waived POCT for infectious diseases, such as influe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohmeier, Kenneth C., McKeirnan, Kimberly, Akers, Julie, Klepser, Michael, Klepser, Stephanie A., Chen, Christe, Klepser, Donald G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287716/
https://www.ncbi.nlm.nih.gov/pubmed/35842688
http://dx.doi.org/10.1186/s43058-022-00324-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287716/
https://www.ncbi.nlm.nih.gov/pubmed/35842688
http://dx.doi.org/10.1186/s43058-022-00324-z

Ejemplares similares